As part of its efforts to guarantee medicine security in the country, the Federal Government on Wednesday signed a Memorandum of Understanding (MOU) with 12 pharmaceutical companies.
Director-General of the National Health Insurance Authority (NHIA), Prof. Mohammed Sambo, disclosed this in Abuja on Wednesday during the signing of MOU with NHIA Medicines Supply Initiative (NMSI).
Sambo said that the initiative was geared towards the strengthening of local pharmaceutical manufacturers, which would ultimately guarantee medicine security.
The Director General said he inaugurated the NMS committee on February 19, 2020 and the committee submitted its report in June 2020.
He also added that he adopted branding of NHIA medicines and other health products as the way to go in order to eradicate out-of- stock syndrome as well as ensuring the quality of its medicines.
The initiative also recommended the setting up of an implementation Committee to bring the initiative to fruition.
Sambo said that the initiative of branding NHIA medicines and other health products was to facilitate the supply of affordable, acceptable, accessible, available and quality medicines and other health products.
According to him, the initiative is to enhance the production of high-quality medicines that will inspire the confidence of users.
“In order to bring this initiative to fruition on August 18th, 2020, I inaugurated the medicines supply implementation Committee. The Committee had its inaugural meeting on September, 22, 2020,’’ he said.
Sambo said that seven States was selected which are Delta, Enugu, Gombe, Jigawa, Niger, Osun and Sokoto states and the FCT for the pilot phase of implementation of this initiative.
He said that a total of 44 submissions were received from pharmaceutical companies and destination management organisation (DMO).
“The submissions were scrutinised and synthesised by the selection committee and 20 companies and eight DMOS were selected to provide services for the initiative.
“Negotiations were held with the selected Pharmaceutical Companies and DMOS. After the negotiations, agreement was reached with 12 Pharmaceutical Companies and 8 DMOS.
“The 12 pharmaceutical companies will be branding 33 products for the health insurance ecosystem in the first phase,’’ he said.
Sambo said the date activity was expected the production of these products at least in the next one month.
The Marketing Manager of Sam Pharmaceutical Ltd., Mr Suresh Nair, said that the company would give the government all the necessary support and also provided quality drugs.
Nair said that the initiative was very important as they would ensure the accessibility of drugs in the country.
